PFE Pfizer Inc.

37.05-0.61 (-1.62%)
Close: November 20, 2019

37.050.00 (+0.01%)
After hours

Quote

Previous Close
$37.05
Day Range
$37.01-$37.69
52 Week Range
$33.97-$46.47
Volume
18,921,127
Avg Volume
18,384,877
Dividend TTM
$1.44 (3.82%)
Ex-Dividend Date
2019-11-07

Valuation

Market Cap
$205.04B
Enterprise Value (EV)
$231.32B
PE Ratio
12.73
EV/EBITDA
10.67
Price/Sales
3.88
Price/Book
3.23
PEG Ratio
-

Financials

Revenue
$53.65B
Gross Profit
$37.64B
EBITDA
$21.67B
EPS, ttm
$2.91
Profit Margin
20.79%
Revenue/Employee
$580.60K
Next Earnings Date
1/28/2020 (69 days)
Debt to Equity
66%
Debt
$45.12B
Cash
$18.83B
Net Debt
$26.28B

Performance

Beta
0.72
200 Day Moving Avg
$39.87
50 Day Moving Avg
$36.66
52 Week Change
-13.48%
YTD Change
-14.54%
1 Month Change
3.29%
3 Month Change
8.81%
6 Month Change
-9.45%
1 Year Change
-13.48%
2 Year Change
6.53%
5 Year Change
23.72%

Share Count

Shares Outstanding
5.5B
Float
5.5B
Restricted Shares
4.3M
Restricted Shares, %
0.08%

Pfizer Inc. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Albert Bourla

Website: http://www.pfizer.com

Description: Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Employees: 92,400